MoneyWorks4Me

Nutraplus India - Quaterly Results

19 Oct 2024 Evaluate
A minor change in the total revenue was seen in the December 2022 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Net Loss for the quarter ended December 2022 is Rs. -0.11 millions as compared to Net Loss of Rs. -0.06 millions of corresponding quarter ended December 2021 Operating profit Margin for the quarter ended December 2022 further decreased to -0.11% as compared to -0.06% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.98 0.00 0.98 0.20 390.00
Other Income 0.00 0.00 0.00 0.00 6.07 0.00 6.20 0.91 581.32
PBIDT -0.11 -0.06 83.33 -1.04 6.72 -115.48 -30.32 -6.11 396.24
Interest 0.00 0.00 0.00 0.26 0.00 0.00 0.00 4.53 -100.00
PBDT -0.11 -0.06 83.33 -1.30 6.72 -119.35 -30.32 -245.16 -87.63
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.11 -0.06 83.33 -1.30 6.72 -119.35 -30.32 -245.16 -87.63
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -8.52 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -8.52 0.00
PAT -0.11 -0.06 83.33 -1.30 6.72 -119.35 -30.32 -236.64 -87.19
Equity 170.46 170.46 0.00 170.46 170.46 0.00 170.46 170.46 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 685.71 0.00 -3093.88 -3055.00 1.27
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..